FindTrial
Sign In

A comparative study to assess the efficacy of standard rTMS Protocol targeting 3 different brain areas in resistant patients of obsessive compulsive disorder.

A prospective interventional study to compare the efficacy of Standard rTMS Protocol targeting Bilateral DLPFC, Right DLPFC and Supplementary Motor Area SMA in patients with treatment resistant obsessive compulsive disorder TROCD. - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099197
Enrollment
30
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F422- Mixed obsessional thoughts and acts

Interventions

Intervention1: rTMSTHERAPY: Standard rTMS protocol targeting bilateral DLPFC, Right DLPFC and SMA in patients with TR-OCD for a total duration of 12 months. Control Intervention1: Multi arm study on s

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ready to provide written informed consent 2. diagnosed case of TR-OCD 3. YBOCS score greater than 20 4. on a stable medication regimen

Exclusion criteria

Exclusion criteria: 1. any contraindication to rTMS 2. comorbid psychiatric disorders in past 6 months 3. significant neurological disorders 4. pregnancy /lactation

Design outcomes

Primary

MeasureTime frame
1. Efficacy of standard rTMS protocol targeting bilateral DLPFC, Right DLPFC, SMA . 2. Response rates 3. Remission Rates Timepoint: 1. Ybocs scores will be applied at baseline, 4 8,12 weeks for checking efficacy 2. Response rates at 4, 8,12 weeks 3. Remission rates at 12 weeks—

Secondary

MeasureTime frame
NILTimepoint:—

Countries

India

Contacts

Public ContactDr Smrity Shailly Bagde

NKP Salve Institute Of Medical Sciences

smrity0609@gmail.com9619157790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026